Role and uptake of human papillomavirus vaccine in adolescent health in the United States.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

1. Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination.Frontiers in oncology · 2016
   Review
2. Alternative dosage schedules with HPV virus-like particle vaccines.Expert review of vaccines · 2014
   Review
3. Application of the Carolina Framework for Cervical Cancer Prevention.Gynecologic oncology · 2014
   Article
4. Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS).PloS one · 2014
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 2 institutions in 1 country.

Funding

Abstract

Indexed as